Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 8:50 pm Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Vivo Opportunity Fund Holdings, L.P. | 1,175,796 4.600% | 563,520 (+92.04%) | Filing |
| 2025-05-15 08:31 am Purchase | 2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX | Vivo Opportunity Fund Holdings, L.P. | 612,276 4.700% | 12,119 (+2.02%) | Filing |
| 2024-12-09 5:37 pm Purchase | 2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX | Vivo Opportunity Fund Holdings, L.P. | 600,157 5.500% | 600,157 (New Position) | Filing |